Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Rapid Study: Haplo-Cord vs MUD Search for AML/MDS
NCT02648932Phase 2Terminated
- Sponsor
- University of Chicago
- Start
- Feb 2016
- Primary completion
- Apr 2020
- Modality
- Hematopoietic Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of umbilical cord blood in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), sponsored by University of Chicago. Started Feb 2016; status: terminated.
02
Drugs
umbilical cord blood
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT02648932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02648932.